: The long-term objective of my research is to define the in vivo role of the receptor tyrosine kinase Ron in liver pathophysiology. Virtually nothing is known regarding the function of Ron in the liver. However, recent studies have shown that Ron signaling modulates hepatic responses in vivo. In order to define the in vivo significance of this receptor, my laboratory generated mice with a targeted ablation of the tyrosine kinase (TK) domain of Ron. These mice, referred to as TK-/- mice, display marked protection compared to control mice in a well characterized model of endotoxin (lipopolysaccharide, LPS) induced acute liver failure in galactosamine (GalN)-sensitized mice. In response to LPS/GalN, control mice exhibit profound hepatocellular injury evaluated by increases in serum aminotransferase levels and hemorrhagic necrosis of the liver. In contrast, the TK-/- mice have mild aminotransferase levels and relatively normal liver histology. The TK-/- mice also display a significant reduction in hepatocyte apoptosis compared to controls. Our preliminary data show that LPS/GalN treatment of TK-/- mice results in diminished levels of IFN-gamma an essential mediator of this injury model, as well as reduced amounts of select chemokines. The reduction in cytokine and chemokine production is associated with a decrease in the number of infiltrating neutrophils into the liver. Based on our preliminary data, this proposal will test the central hypothesis that Ron receptor signaling promotes the progression of acute liver failure by augmenting IFN-( and select chemokine production, leading to an increase in neutrophil recruitment, hepatocyte apoptosis and acute liver failure. In order to test this hypothesis, three specific aims are proposed.
Aim I will delineate the Ron-dependent cell type-specific mechanism responsible for augmenting IFN-( levels.
Aim II will define the Ron-dependent Kupffer cell-mediated mechanism required for promoting hepatocyte apoptosis.
Aim III will establish the requirement for Ron-dependent chemokine production in neutrophil mobilization to the liver. In total, we hope to understand the role of a potentially important receptor in liver biology with the hopes of impacting the treatment of human liver disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK073552-10
Application #
7650166
Study Section
Hepatobiliary Pathophysiology Study Section (HBPP)
Program Officer
Doo, Edward
Project Start
1999-07-01
Project End
2011-06-30
Budget Start
2009-07-01
Budget End
2011-06-30
Support Year
10
Fiscal Year
2009
Total Cost
$288,835
Indirect Cost
Name
University of Cincinnati
Department
Surgery
Type
Schools of Medicine
DUNS #
041064767
City
Cincinnati
State
OH
Country
United States
Zip Code
45221
Stuart, William D; Brown, Nicholas E; Paluch, Andrew M et al. (2015) Loss of Ron receptor signaling leads to reduced obesity, diabetic phenotypes and hepatic steatosis in response to high-fat diet in mice. Am J Physiol Endocrinol Metab 308:E562-72
Gurusamy, Devikala; Gray, Jerilyn K; Pathrose, Peterson et al. (2013) Myeloid-specific expression of Ron receptor kinase promotes prostate tumor growth. Cancer Res 73:1752-63
Kulkarni, Rishikesh M; Kutcher, Louis W; Stuart, William D et al. (2012) Ron receptor-dependent gene regulation in a mouse model of endotoxin-induced acute liver failure. Hepatobiliary Pancreat Dis Int 11:383-92
Nikolaidis, Nikolaos M; Kulkarni, Rishikesh M; Gray, Jerilyn K et al. (2011) Ron receptor deficient alveolar myeloid cells exacerbate LPS-induced acute lung injury in the murine lung. Innate Immun 17:499-507
Stuart, William D; Kulkarni, Rishikesh M; Gray, Jerilyn K et al. (2011) Ron receptor regulates Kupffer cell-dependent cytokine production and hepatocyte survival following endotoxin exposure in mice. Hepatology 53:1618-28
Meyer, Sara E; Peace, Belinda E; Bahassi, El Mustapha et al. (2010) Chk2*1100delC Acts in synergy with the Ron receptor tyrosine kinase to accelerate mammary tumorigenesis in mice. Cancer Lett 296:186-93
Nikolaidis, Nikolaos M; Gray, Jerilyn K; Gurusamy, Devikala et al. (2010) Ron receptor tyrosine kinase negatively regulates TNFalpha production in alveolar macrophages by inhibiting NF-kappaB activity and Adam17 production. Shock 33:197-204
Caldwell, Charles C; Martignoni, Andre; Leonis, Mike A et al. (2008) Ron receptor tyrosine kinase-dependent hepatic neutrophil recruitment and survival benefit in a murine model of bacterial peritonitis. Crit Care Med 36:1585-93
Wetzel, Cynthia C; Leonis, Mike A; Dent, Arlene et al. (2007) Short-form Ron receptor is required for normal IFN-gamma production in concanavalin A-induced acute liver injury. Am J Physiol Gastrointest Liver Physiol 292:G253-61
Leonis, Mike A; Thobe, Megan N; Waltz, Susan E (2007) Ron-receptor tyrosine kinase in tumorigenesis and metastasis. Future Oncol 3:441-8

Showing the most recent 10 out of 14 publications